HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Pautas Selected Research

Transplantation

4/2007[Early pneumonia after allogenic stem cell transplantation].
1/2007Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantation.
5/2005New findings and key questions in hematopoietic stem cell transplantation.
3/2004Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Pautas Research Topics

Disease

7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2012 - 11/2000
5Leukemia
04/2017 - 05/2004
2Aspergillosis
01/2009 - 05/2005
2Pure Red-Cell Aplasia
08/2007 - 01/2007
2Graft vs Host Disease (Graft-Versus-Host Disease)
05/2005 - 05/2004
2Infections
05/2005 - 05/2004
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2017
1Hematologic Neoplasms (Hematological Malignancy)
04/2017
1Wilms Tumor (Wilm's Tumor)
06/2012
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2009
1Spondylitis
11/2009
1Pneumonia (Pneumonitis)
04/2007
1Invasive Fungal Infections
05/2004
1Bronchiolitis Obliterans Syndrome
03/2004
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2004
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2004
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2004
1Cardiotoxicity
11/2000
1Mucositis
11/2000
1Toxoplasmosis
08/2000

Drug/Important Bio-Agent (IBA)

2Mitoxantrone (Novantrone)FDA LinkGeneric
07/2005 - 11/2000
2Cytarabine (Cytosar-U)FDA LinkGeneric
07/2005 - 11/2000
2Etoposide (VP 16)FDA LinkGeneric
07/2005 - 11/2000
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
06/2012
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2012
1NucleophosminIBA
06/2012
1DNA Methyltransferase 3AIBA
06/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2009
1Infliximab (Remicade)FDA Link
11/2009
1AntigensIBA
01/2009
1galactomannanIBA
01/2009
1Hemagglutinins (Hemagglutinin)IBA
08/2007
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2007
1Gemtuzumab (Mylotarg)FDA Link
01/2007
1Biomarkers (Surrogate Marker)IBA
05/2005
1Core Binding Factors (Core-Binding Factor)IBA
04/2005
1Voriconazole (Vfend)FDA LinkGeneric
05/2004
1Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2004
1CalcineurinIBA
03/2004
1Rituximab (Mabthera)FDA Link
03/2004
1Transaminases (Aminotransferases)IBA
11/2000
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
08/2000

Therapy/Procedure

7Therapeutics
11/2009 - 08/2000
5Stem Cell Transplantation
04/2007 - 04/2005
4Transplantation
04/2007 - 03/2004
2Hematopoietic Stem Cell Transplantation
04/2017 - 08/2007
2Drug Therapy (Chemotherapy)
07/2005 - 11/2000
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
03/2004